(Q33399582)

English

A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma

scientific article

Statements

A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma (English)
Swiss SAKK and French GOELAMS group from European Mantle Cell Lymphoma Network

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit